NA, a precursor of NAD, prevents excess STZ-induced damage of islet cells by inhibition of PARP-1 activity and increasing intracellular NAD and thus ensuring stable T2DM(18,58). The gene discussed is PARP1; the disease is type 2 diabetes mellitus.